Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review

Farhana Haseen, MM Cantwell, JM O'Sullivan, LJ Murray

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Lycopene has a chemopreventive effect against prostate cancer but its role in prostate cancer progression is unknown; many patients increase their intake of lycopene, although there are no evidence-based guidelines to suggest an effect. Our objective was to conduct a systematic review of literature to evaluate the association between lycopene intake and prostate cancer progression. MEDLINE, EMBASE CINAHL Plus, Web of Science, AMED and CENTRAL databases were systematically searched using terms for lycopene and prostate cancer progression to identify studies published before January 2009. Eight intervention studies were identified (five with no control group; one with an unmatched control group; and two randomized controlled trials (RCTs)). An inverse association was observed between lycopene intake and PSA levels in six studies. The rates of progression measured by bone scan in one RCT were lower in the intervention group. Lycopene resulted in lowering cancer-related symptoms (pain, urinary tract symptoms), and severe toxicity or intolerance was not evident. However, the evidence available to date is insufficient to draw a firm conclusion with respect to lycopene supplementation in prostate cancer patients and larger RCTs are required in broader patient groups.

Original languageEnglish
Pages (from-to)325-332
Number of pages8
JournalProstate Cancer and Prostatic Diseases
Volume12
Issue number4
Early online date1 Sep 2009
DOIs
Publication statusPublished - 2009

Fingerprint

Prostatic Neoplasms
Randomized Controlled Trials
Control Groups
lycopene
Urinary Tract
MEDLINE
Databases
Guidelines
Bone and Bones

Cite this

Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. / Haseen, Farhana; Cantwell, MM; O'Sullivan, JM; Murray, LJ.

In: Prostate Cancer and Prostatic Diseases, Vol. 12, No. 4, 2009, p. 325-332.

Research output: Contribution to journalArticle

Haseen, Farhana ; Cantwell, MM ; O'Sullivan, JM ; Murray, LJ. / Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. In: Prostate Cancer and Prostatic Diseases. 2009 ; Vol. 12, No. 4. pp. 325-332.
@article{196abe1c583f4dc1aaee8970e6ef3a2d,
title = "Is there a benefit from lycopene supplementation in men with prostate cancer?: A systematic review",
abstract = "Lycopene has a chemopreventive effect against prostate cancer but its role in prostate cancer progression is unknown; many patients increase their intake of lycopene, although there are no evidence-based guidelines to suggest an effect. Our objective was to conduct a systematic review of literature to evaluate the association between lycopene intake and prostate cancer progression. MEDLINE, EMBASE CINAHL Plus, Web of Science, AMED and CENTRAL databases were systematically searched using terms for lycopene and prostate cancer progression to identify studies published before January 2009. Eight intervention studies were identified (five with no control group; one with an unmatched control group; and two randomized controlled trials (RCTs)). An inverse association was observed between lycopene intake and PSA levels in six studies. The rates of progression measured by bone scan in one RCT were lower in the intervention group. Lycopene resulted in lowering cancer-related symptoms (pain, urinary tract symptoms), and severe toxicity or intolerance was not evident. However, the evidence available to date is insufficient to draw a firm conclusion with respect to lycopene supplementation in prostate cancer patients and larger RCTs are required in broader patient groups.",
author = "Farhana Haseen and MM Cantwell and JM O'Sullivan and LJ Murray",
year = "2009",
doi = "10.1038/pcan.2009.38",
language = "English",
volume = "12",
pages = "325--332",
journal = "Prostate Cancer and Prostatic Diseases",
issn = "1365-7852",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Is there a benefit from lycopene supplementation in men with prostate cancer?

T2 - A systematic review

AU - Haseen, Farhana

AU - Cantwell, MM

AU - O'Sullivan, JM

AU - Murray, LJ

PY - 2009

Y1 - 2009

N2 - Lycopene has a chemopreventive effect against prostate cancer but its role in prostate cancer progression is unknown; many patients increase their intake of lycopene, although there are no evidence-based guidelines to suggest an effect. Our objective was to conduct a systematic review of literature to evaluate the association between lycopene intake and prostate cancer progression. MEDLINE, EMBASE CINAHL Plus, Web of Science, AMED and CENTRAL databases were systematically searched using terms for lycopene and prostate cancer progression to identify studies published before January 2009. Eight intervention studies were identified (five with no control group; one with an unmatched control group; and two randomized controlled trials (RCTs)). An inverse association was observed between lycopene intake and PSA levels in six studies. The rates of progression measured by bone scan in one RCT were lower in the intervention group. Lycopene resulted in lowering cancer-related symptoms (pain, urinary tract symptoms), and severe toxicity or intolerance was not evident. However, the evidence available to date is insufficient to draw a firm conclusion with respect to lycopene supplementation in prostate cancer patients and larger RCTs are required in broader patient groups.

AB - Lycopene has a chemopreventive effect against prostate cancer but its role in prostate cancer progression is unknown; many patients increase their intake of lycopene, although there are no evidence-based guidelines to suggest an effect. Our objective was to conduct a systematic review of literature to evaluate the association between lycopene intake and prostate cancer progression. MEDLINE, EMBASE CINAHL Plus, Web of Science, AMED and CENTRAL databases were systematically searched using terms for lycopene and prostate cancer progression to identify studies published before January 2009. Eight intervention studies were identified (five with no control group; one with an unmatched control group; and two randomized controlled trials (RCTs)). An inverse association was observed between lycopene intake and PSA levels in six studies. The rates of progression measured by bone scan in one RCT were lower in the intervention group. Lycopene resulted in lowering cancer-related symptoms (pain, urinary tract symptoms), and severe toxicity or intolerance was not evident. However, the evidence available to date is insufficient to draw a firm conclusion with respect to lycopene supplementation in prostate cancer patients and larger RCTs are required in broader patient groups.

U2 - 10.1038/pcan.2009.38

DO - 10.1038/pcan.2009.38

M3 - Article

VL - 12

SP - 325

EP - 332

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - 4

ER -